<prompt> Answer this question truthfullyWhat is the potential risk associated with combining non-dihydropyridine calcium channel blockers CCBs and β-adrenergic antagonists, and what is the effect?  <response>: <reason> Non-dihydropyridine CCBs may cause excessive AV block when combined with β-adrenergic antagonists, which can lead to serious cardiovascular complications. 